| Dr Ralph Timothy Dunnigan, MD | |
|
401 N 9th St, Bismarck, ND 58501-4530 | |
| (701) 712-4500 | |
| Not Available |
| Full Name | Dr Ralph Timothy Dunnigan |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 35 Years |
| Location | 401 N 9th St, Bismarck, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932151586 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 6681 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi St Alexius Health | Bismarck, ND | Hospital |
| Sanford Medical Center Bismarck | Bismarck, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Omaha Therapy Inc | 1557270915 | 45 |
| Innovis Health Llc | 9931298155 | 473 |
News Archive
The Squash Diabetes Campaign was launched today by the Georgetown University Women's Squash Team, where a team member successfully competes in the vigorous game of squash despite the health challenges of Type 1 (Juvenile) diabetes.
Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).
LifeCycle Pharma A/S (OMX: LCP) announced today that the Board of Directors of LCP and Jim New have agreed to terminate the contract with Jim New. Hence, Jim New will with immediate effect step down as the President and CEO of LCP. The termination is related to different views on how an international company based in Scandinavia shall be managed.
"G20 farm ministers settled a deal on Thursday to tackle high food prices, agreeing to a watered-down declaration that fell short of France's ambitious proposals to tighten regulation of commodity markets," Reuters reports.
› Verified 4 days ago
| Entity Name | Mid Dakota Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275587826 PECOS PAC ID: 9638072895 Enrollment ID: O20040127001063 |
News Archive
The Squash Diabetes Campaign was launched today by the Georgetown University Women's Squash Team, where a team member successfully competes in the vigorous game of squash despite the health challenges of Type 1 (Juvenile) diabetes.
Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).
LifeCycle Pharma A/S (OMX: LCP) announced today that the Board of Directors of LCP and Jim New have agreed to terminate the contract with Jim New. Hence, Jim New will with immediate effect step down as the President and CEO of LCP. The termination is related to different views on how an international company based in Scandinavia shall be managed.
"G20 farm ministers settled a deal on Thursday to tackle high food prices, agreeing to a watered-down declaration that fell short of France's ambitious proposals to tighten regulation of commodity markets," Reuters reports.
› Verified 4 days ago
| Entity Name | Innovis Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215125463 PECOS PAC ID: 9931298155 Enrollment ID: O20071211000158 |
News Archive
The Squash Diabetes Campaign was launched today by the Georgetown University Women's Squash Team, where a team member successfully competes in the vigorous game of squash despite the health challenges of Type 1 (Juvenile) diabetes.
Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).
LifeCycle Pharma A/S (OMX: LCP) announced today that the Board of Directors of LCP and Jim New have agreed to terminate the contract with Jim New. Hence, Jim New will with immediate effect step down as the President and CEO of LCP. The termination is related to different views on how an international company based in Scandinavia shall be managed.
"G20 farm ministers settled a deal on Thursday to tackle high food prices, agreeing to a watered-down declaration that fell short of France's ambitious proposals to tighten regulation of commodity markets," Reuters reports.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ralph Timothy Dunnigan, MD 401 N 9th St, Bismarck, ND 58501-4530 Ph: (701) 712-4500 | Dr Ralph Timothy Dunnigan, MD 401 N 9th St, Bismarck, ND 58501-4530 Ph: (701) 712-4500 |
News Archive
The Squash Diabetes Campaign was launched today by the Georgetown University Women's Squash Team, where a team member successfully competes in the vigorous game of squash despite the health challenges of Type 1 (Juvenile) diabetes.
Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).
LifeCycle Pharma A/S (OMX: LCP) announced today that the Board of Directors of LCP and Jim New have agreed to terminate the contract with Jim New. Hence, Jim New will with immediate effect step down as the President and CEO of LCP. The termination is related to different views on how an international company based in Scandinavia shall be managed.
"G20 farm ministers settled a deal on Thursday to tackle high food prices, agreeing to a watered-down declaration that fell short of France's ambitious proposals to tighten regulation of commodity markets," Reuters reports.
› Verified 4 days ago
Dr. Jess A Miller, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-5422 Fax: 701-323-8645 | |
Stephanie Ann Lill Miller, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2830 N Washington St, Bismarck, ND 58503 Phone: 701-323-6000 | |
Cheryl E Huber, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1800 E Interstate Ave Ste B, Bismarck, ND 58503 Phone: 701-323-6543 | |
Gabriela Balf-soran, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3501 Chisholm Trl, Bismarck, ND 58503 Phone: 203-707-0881 Fax: 701-425-0596 | |
Dr. Laura B Schield, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2787 97th Ave Nw, Bismarck, ND 58503 Phone: 701-223-0592 | |
Dr. Bryon Lee Herbel, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 303 N 4th St, Bismarck, ND 58501 Phone: 701-223-2425 | |
John Riedinger, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4535 Northern Sky Dr, Bismarck, ND 58503 Phone: 701-323-8700 |